Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.
暂无分享,去创建一个
K. Lindenberg | B. Woodman | G. Landwehrmeyer | G B Landwehrmeyer | P F Behrens | P Franz | B Woodman | K S Lindenberg | P. Franz | P. F. Behrens
[1] M. Figiel,et al. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), a Neuron-Derived Peptide Regulating Glial Glutamate Transport and Metabolism , 2000, The Journal of Neuroscience.
[2] P. Fürst,et al. An ultra rapid and sensitive high-performance liquid chromatographic method for determination of tissue and plasma free amino acids. , 1985, Analytical biochemistry.
[3] S. Amara,et al. Excitatory amino acid transporters: a family in flux. , 1999, Annual review of pharmacology and toxicology.
[4] L. Massieu,et al. Glutamate Uptake Impairment and Neuronal Damage in Young and Aged Rats In Vivo , 1997, Journal of neurochemistry.
[5] J. Eberwine,et al. Hunting in the calm before the storm , 2000, Nature Genetics.
[6] M. Hediger,et al. Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate , 1996, Neuron.
[7] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[8] G. Reynolds,et al. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease , 1986, Neuroscience Letters.
[9] S. W. Davies,et al. Detection of polyglutamine aggregation in mouse models. , 1999, Methods in enzymology.
[10] Masahiko Watanabe,et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. , 1997, Science.
[11] C A Ross,et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.
[12] J. Rothstein,et al. Traumatic Brain Injury Down‐Regulates Glial Glutamate Transporter (GLT‐1 and GLAST) Proteins in Rat Brain , 1998, Journal of neurochemistry.
[13] M. Norenberg,et al. Glutamine synthetase: glial localization in brain , 1977, Science.
[14] J. Storm-Mathisen,et al. Down‐regulation of Glial Glutamate Transporters after Glutamatergic Denervation in the Rat Brain , 1995, The European journal of neuroscience.
[15] G. Ojemann,et al. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy , 1999, Neurology.
[16] J. Rothstein,et al. Fimbria‐Fornix Transections Selectively Down‐Regulate Subtypes of Glutamate Transporter and Glutamate Receptor Proteins in Septum and Hippocampus , 1996, Journal of neurochemistry.
[17] R. Swanson,et al. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions , 2000, Glia.
[18] K. Kashfi,et al. Lipid Metabolism and Membrane Composition Are Altered in the Brains of Type II Diabetic Mice , 1995, Journal of neurochemistry.
[19] S. Tabrizi,et al. Biochemical abnormalities and excitotoxicity in Huntington's disease brain , 1999, Annals of neurology.
[20] G. Reynolds,et al. Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain , 1987, Neuroscience Letters.
[21] Huda Y. Zoghbi,et al. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1 , 2000, Nature Neuroscience.
[22] J. Draeger,et al. Extracellular Glutamate and Other Metabolites in and Around RG2 Rat Glioma: An Intracerebral Microdialysis Study , 2000, Journal of Neuro-Oncology.
[23] Joseph B. Martin. Huntington's disease , 1984, Neurology.
[24] He Li,et al. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity , 2000, Nature Genetics.
[25] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[26] M. Yudkoff,et al. Compartmentation of brain glutamate metabolism in neurons and glia. , 2000, The Journal of nutrition.
[27] J. McGinty,et al. l‐trans‐Pyrrolidine‐2,4‐Dicarboxylic Acid‐Evoked Striatal Glutamate Levels Are Attenuated by Calcium Reduction, Tetrodotoxin, and Glutamate Receptor Blockade , 1997, Journal of neurochemistry.
[28] G. Landwehrmeyer,et al. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[29] M. Korte,et al. Cerebral Taurine Release Mechanisms In Vivo: Pharmacological Investigations in Rats Using Microdialysis for Proof of Principle , 2000, Neurochemical Research.
[30] J. Cha,et al. Transcriptional dysregulation in Huntington’s disease , 2000, Trends in Neurosciences.
[31] J. Penney,et al. Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease , 1992, Annals of neurology.
[32] I. Reymond,et al. Immunocytochemical localization of cysteine sulfinate decarboxylase in astrocytes in the cerebellum and hippocampus: a quantitative double immunofluorescence study with glial fibrillary acidic protein and S-100 protein , 1996, Neuroscience.
[33] M. Beal,et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.
[34] A Weindl,et al. Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntington's Disease—An In Situ Hybridization Study , 1997, Journal of neuropathology and experimental neurology.
[35] C. Crosson,et al. Modulation of Human Glutamate Transporter Activity by Phorbol Ester , 1998, Journal of neurochemistry.
[36] D. Schoepp,et al. Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.
[37] Carlos Cepeda,et al. Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease , 1999, Journal of neuroscience research.
[38] T. Perry. POST-MORTEM FINDINGS DO NOT SUGGEST A BRAIN GLUTAMINE DEFICIENCY IN HUNTINGTON'S DISEASE , 1981, The Lancet.
[39] Effects of uptake carrier blockers SK & F 89976-A and L-trans-PDC on in vivo release of amino acids in rat hippocampus. , 1996, European journal of pharmacology.
[40] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[41] D. Standaert,et al. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia , 1998, The Journal of comparative neurology.
[42] M. Kavanaugh,et al. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. , 1999, Current pharmaceutical design.
[43] Robert H. Brown,et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter , 1999, Nature Neuroscience.
[44] M. Robinson,et al. Subtypes of Sodium‐Dependent High‐Affinity L‐[3H]Glutamate Transport Activity: Pharmacologic Specificity and Regulation by Sodium and Potassium , 1993, Journal of neurochemistry.
[45] E. Masliah,et al. Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease , 1996 .
[46] M. Beal,et al. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] F. Mora,et al. Endogenous Glutamate Increases Extracellular Concentrations of Dopamine, GABA, and Taurine Through NMDA and AMPA/Kainate Receptors in Striatum of the Freely Moving Rat: A Microdialysis Study , 1997, Journal of neurochemistry.
[48] Leif Hertz,et al. Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters , 1979, Progress in Neurobiology.
[49] J. Rothstein,et al. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-κB , 2000 .
[50] O. Andreassen,et al. Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice , 2000, Journal of neurochemistry.
[51] S. W. Davies,et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Penney,et al. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. , 1998, Brain research. Brain research protocols.
[53] P. Salin,et al. Continuous administration of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion. , 1997, Brain research. Molecular brain research.
[54] R. Heavens,et al. Retrieval of cellular mRNA in paraffin-embedded human brain using hydrated autoclaving , 1997, Journal of Neuroscience Methods.
[55] S. W. Davies,et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[56] G. Reynolds,et al. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases , 1985, Journal of the Neurological Sciences.
[57] P. Robson,et al. Glutamine, exercise and immune function: Links and possible mechanisms , 1999 .
[58] R. Huxtable. Taurine in the central nervous system and the mammalian actions of taurine , 1989, Progress in Neurobiology.
[59] R. Albin,et al. Alternative excitotoxic hypotheses , 1992, Neurology.
[60] M. Beal,et al. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.
[61] J. Rothstein,et al. Regional Deafferentiation Down‐Regulates Subtypes of Glutamate Transporter Proteins , 1995, Journal of neurochemistry.
[62] J. Rothstein,et al. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.
[63] P. Salin,et al. Differential Effects of Corticostriatal and Thalamostriatal Deafferentation on Expression of the Glutamate Transporter GLT1 in the Rat Striatum , 2000, Journal of neurochemistry.
[64] S. W. Davies,et al. Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation , 1999, Journal of neurochemistry.
[65] L. Massieu,et al. Accumulation of Extracellular Glutamate by Inhibition of Its Uptake Is Not Sufficient for Inducing Neuronal Damage: An In Vivo Microdialysis Study , 1995, Journal of neurochemistry.
[66] A. Volterra,et al. The Competitive Transport Inhibitor L‐trans‐pyrrolidine‐2,4‐dicarboxylate Triggers Excitotoxicity in Rat Cortical Neuron‐Astrocyte Co‐cultures via Glutamate Release rather than Uptake Inhibition , 1996, The European journal of neuroscience.
[67] J. Rothstein,et al. Neuronal Regulation of Glutamate Transporter Subtype Expression in Astrocytes , 1997, The Journal of Neuroscience.
[68] O. Ottersen,et al. Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus , 2004, Experimental Brain Research.